Abstract
Although the emphasis on identifying uremic toxins has centered around organic compounds, it is now apparent that inorganic solutes also may be responsible for some of the symptomatology of the uremic state. The importance of such electrolyte disturbances as the cardiac and neuromuscular effects of hyperkalemia and hypermagnesemia, the extraskeletal calcification caused by hyperphosphatemia and hypertension induced by excess body sodium and water have been studied repeatedly. However, little attention has been directed toward trace element disturbances and their physiological consequences in dialyzed uremic patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mertz W: Trace element nutrition in health and disease: contributions and problems of analysis. Clin Chem 21: 468, 1975
Sprague SM, Fregene A, Wilkinson G, Costantino J, Rosenbaum RW, Mayor GH: Serum vanadium (V) concentration in chronic renal failure (CRF). Abstracts Am Soc Nephrol 13: 108A, 1980
Bello-Reuss EN, Grady TP, Mazumdar DC: Serum vanadium levels in chronic renal disease. Ann Intern Med 91: 743, 1979
Kallistratos A, Evangelou A, Seferiadis P, Vezyraki P, Barboutis K: Selenium and haemodialysis: serum selenium levels in healthy persons, non-cancer and cancer patients with chronic renal failure. Nephron 41: 217, 1985
Dworkin B, Weseley S, Rosenthal WS, Schwartz EM, Weiss L: Diminished blood selenium levels in renal failure patients on dialysis: correlations with nutritional status. Am J Med Sci 293: 6, 1987
Muirhead N, Kertesz A, Flanagan PR, Hodsman AB, Hollomby DJ, Valberg LS: Zinc metabolism in patients on maintenance hemodialysis. Am J Nephrol 6: 422, 1986
McNeely MD, Sunderman FW Jr, Michay MW, Levine H: Abnormal concentrations of nickel in serum in case of myocardial infarction, stroke, burns, hepatic cirrhosis and uremia. Clin Chem 17: 1123, 1971
Hosokawa S, Nishitani H, Umemura K, Tomoyoshi T, Sawanishi K, Osamu Y: Serum and corpuscular nickel and zinc in chronic hemodialysis patients. Nephron 45: 151, 1987
Drazniowsky M, Parkinson IS, Ward MK, Channon SM, Kerr DNS: A method for the determination of nickel in water and serum by flameless atomic absorption spectrometry. Clin Chim Acta 145: 219, 1985
Dobbie JW, Smith MJB: The silicon content of body fluids. Scott Med J 27: 17, 1982
Berlyne G, Dudek E, Adler A J, Rubin JE, Seidman M: Silicon metabolism: The basic facts in renal failure. Kidney Int 28 (Suppl 17): S-175, 1985
Adler AJ, Berlyne GM: Silicon metabolism. II. Renal handling in chronic renal failure patients. Nephron 44: 36, 1986
Brune D, Samasahl K, Wester PO: A comparison between the amounts of As, Au, Br, Cu, Fe, Mo, Se and Zn in normal and uraemic human whole blood by means of neutron activation analysis. Clin Chim Acta 13: 285, 1966
Bergström J, Wester PO: The effect of dialysis on the arsenic content of blood and muscle tissue from uraemic patients. Proc Eur Dial Transplant Assoc 3: 38, 1966
Rudolph H, Alfrey AC, Smythe WR: Muscle and serum trace element profile in uremia. Trans Am Soc Artif Intern Organs 19: 456, 1973
Alfrey AC, Durr JA, Miller N: The determination of endogenous lithium (Li) as a marker of proximal tubular Na and H2O handling. Clin Nephrol 19: 32A, 1986
Kaehny WD, Alfrey AC, Holman RC, Schorr WJ: Aluminum transfer during hemodialysis. Kidney Int 12: 361, 1977
Smythe WR, Alfrey AC, Craswell PW, Crouch CA, Ibels LS, Kubo H, Nunnelley LL, Rudolph H: Trace metal abnormalities in chronic uremia. Ann Intern Med 96: 302, 1982
Indraprasit S, Alexander GV, Gonick HC: Tissue composition of major and trace elements in uremia and hypertension. J Chronic Dis 27: 135, 1974
Cordy PE, Gagnon R, Taves DR, Kay M: Bone disease in hemodialysis patients with particular reference to the effect of fluoride. Trans Am Soc Artif Intern Organs 20: 197, 1974
Alfrey AC, Smythe WR, Ibels LS, Nunnelley LL: Trace Element Abnormalities in Chronic Uremia. 2nd Annu Prog Report, Springfield, VA, National Technical Information Service, 1976, p 35
Spencer H, Lewin I, Belcher MJ, Scamachson J: Inhibition of radiostrontium absorption. Int J Appl Radiat Isot 20: 507, 1969
Nunnelley LL, Smythe WR, Alfrey AC, Ibels LS: Uremic hyperstannum: elevated tissue tin levels associated with uremia. J Lab Clin Med 91: 72, 1978
Antoniou LD, Shalhoub RJ, Sudhakar T, Smith JC Jr: Reversal of uraemic impotence by zinc. Lancet 2: 895, 1977
Atkin-Thor E, Goddward BW, O’Nion J, Stephen RL, Kolff WJ: Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr 31: 1948, 1978
Kaehny WD, Hegg AP, Alfrey AC: Gastrointestinal absorption of aluminum from aluminum containing antacids. N Engl J Med 296: 1839, 1977
Gorsky JE, Dietz AA, Spencer H, Osis D: Metabolic balance of aluminum studied in six men. Clin Chem 25: 1739, 1979
Kovalchik MT, Kaehny WD, Jackson T, Alfrey AC: Aluminum kinetics during hemodialysis. J Lab Clin Med 92: 712, 1978
Gallery ED, Blomfield J, Dixon SF: Acute zinc toxicity in haemodialysis. Br Med J 4: 331, 1972
Ivanovich P, Manzler A, Drake R: Acute hemolysis following hemodialysis. Trans Am Soc Artif Intern Organs 15: 316, 1969
Klein WJ, R, Metz EN, Price AR: Acute copper intoxication. Arch Intern Med 129: 578, 1972
Manzler AD, Schreiner AW: Copper-induced acute hemolytic anemia. Ann Intern Med 73: 409, 1970
Matter BJ, Pederson J, Psimenos G, Lindeman RD: Lethal copper intoxication in hemodialysis. Trans Am Soc Artif Intern Organs 15: 309, 1969
Lyle WH, Payton JE, Jui M: Hemodialysis and copper fever. Lancet 1: 1324, 1976
Webster JD, Parker TF, Alfrey AC, Smythe WR, Kubo H, Neal G, Hull AR: Acute nickel intoxication by dialysis. Ann Intern Med 92: 631, 1980
Mitchell G, Cirksena W, Samaras G, Wax C: Acute fluoride intoxication in hemodialysis patients. Abstracts Am Soc Nephrol 13: 47A, 1980
Johnson WJ, Taves DR: Exposure to excessive fluoride during hemodialysis. Kidney Int 5: 451, 1974
Alfrey AC, LeGendre GR, Kaehny WD: The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294: 184, 1976
McDermott JR, Smith AI, Ward MK, Fawcett RWP, Kerr DNS: Brain-aluminium concentration in dialysis encephalopathy. Lancet 1: 901, 1978
Carder F, Allain P, Gary J, Chatel M, Menault F, Pecker S: Encephalopathie myoclonique progressive des dialyses. Role de l’eau utilisee pour l’hemodialyse. (Progressive myoclonic dialysis encephalopathy. Significance of the water utilized for preparation of dialysis fluid.) Nouv Presse Med 7: 97, 1978
Crapper DR, Quittkat S, Krishnan SS, Dalton AJ, DeBoni U: Intranuclear aluminum content in Alzheimer’s disease, dialysis encephalopathy and experimental aluminum encephalopathy. Acta Neuropathol 50: 19, 1980
Parkinson IS, Ward MK, Feest TG, Fawcett RWP, Kerr DNS: Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1: 406, 1979
Platts MM, Goode GC, Hislop JS: Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J 2: 657, 1977
Klatzo I, Wisniewski H, Streicher E: Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J Neuropathol Exp Neurol 24: 187, 1965
Lapresle J, Duckett S, Galle P, Cartier L: Documents cliniques, anatomiques et biophysiques dans une encephalopathie avec presence de depots d’aluminum. (Clinical anatomical and biophysical data of a case of encephalopathy with accumulation of aluminum.) C R Soc Biol (Paris) 169: 282, 1975
McLaughlin AIG, Kazantzis G, King E, Teare D, Porter RJ, Owen R: Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminum dust. Br J Ind Med 19: 282, 1975
Crapper DR, Krishman SS, Dalton AJ: Brain aluminum distribution in Alzheimer’s disease and experimental neurofibrillary degeneration. Science 180: 511, 1973
Pierides AM, Edwards WG, Jr, Cullum UX, Jr, McCall JT, Ellis HA: Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness. Kidney Int 18: 115, 1980
Hodsman AB, Sherrard DJ, Brickman AS, Alfrey AC, Goodman WG, Maloney N, Lee DBN, Coburn JW: Bone aluminum in osteomalacic renal osteodystrophy correlation with excess osteoid. Abstracts Am Soc Neprhol 13: 20A, 1980
Buchet JP, Lauwerys R, Hassoun A, Dratwa M, Wens R, Collart F, Tielemans C: Effect of aluminum on porphyrin metabolism in hemodialyzed patients. Nephron 46: 360, 1987
Manifold IH, Platts MM, Kennedy A: A cobalt cardiomyopathy in a patient on maintenance haemodialysis. Br Med J 2: 1609, 1978
Pehrsson K, Lins LE: Cobalt in uremic cardiomyopathy. Lancet 2: 51, 1978
Posen GA, Taves DR, Marier JR, Jaworski ZF: Renal osteodystrophy in long-term hemodialysis with fluoridated water. Abstracts Am Soc Nephrol 2: 51, 1968
Omdahl JL, DeLuca HF: Strontium induced rickets: metabolic basis. Science 174: 949, 1971
Piscator M: The chronic toxicity of cadmium, in: Trace Elements in Human Health and Disease, edited by Prasad AS, New York, Academic Press, 2, 1976, p 431
Blendis LM, Ampil M, Wilson DR, Kiwan J, Labranche J, Johnson M, Williams C: The importance of dietary protein in the zinc deficiency of uremia. Am J Clin Nutr 34: 2658, 1981
Bodgen JD, Oleske JM, Weiner B, Smith LG Jr, Smith LG, Najem GR: Elevated plasma zinc concentrations in renal dialysis patients. Am J Clin Nutr 33: 1088, 1980
Kiilerich S, Christiansen C, Crisensen MS, Naestoft J: Zinc metabolism in patients with chronic renal failure during treatment with 1, 25-dihydroxy-cholecalciferol: a controlled therapeutic trial. Clin Nephrol 15: 23, 1981
Michael J, Hilton PJ, Jones NF: Zinc and the sodium pump in uremia. Am J Clin Nutr 31: 1945, 1978
Mountokalakis T, Dakanlis D, Boukis D, Virvidakis K, Voudiklari S, Koutselinis A: Hair zinc compared with plasma zinc in uremic patients, before and during regular hemodialysis. Clin Nephrol 12: 206, 1979
Paniagua-Sierra JR, Perez-Lopez A, Diaz-Bensussen S, Solis-Alpuche L, Saavedre-Guatemala H, Exaire-Murad JE: Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure. Arch Invest Med (Mex) 12: 69, 1981
Siegler RL, Eggert JV, Udokesmalee E: Diagnostic indices of zinc deficiency in children with renal disease. Ann Clin Lab Sci 11: 428, 1981
Zumkley H, Bertram HP, Lison A, Knoll O, Losse H: Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency. Clin Nephrol 12: 18, 1979
Mahajan SK, Abassi AA, Prasad AS, Rabbini P, Briggs WA, McDonald FD: Effect of oral zinc therapy on gonadal function in hemodialysis patients: a double blind study. Ann Intern Med 91: 357, 1982
Mahajan SK, Hamburger RJ, Flamenbaum W, Prasad AS, McDonald FD: Effect of zinc supplementation on hyperprolactinaemia in uraemic men. Lancet 2: 758, 1985
Antoniou LD, Shalhoub RJ: Zinc and sexual dysfunction. Lancet 8: 1034, 1980
Brook AC, Johnston DG, Ward MK, Watson MJ, Cook DB, Kerr DN: Absence of a therapeutic effect of zinc in the sexual dysfunction of haemodialyzed patients. Lancet 2: 618, 1980
Joven J, Villabona C, Rubies-Prat J, Espinel E, Galard R: Hormonal profile and serum zinc levels in uraemic men with gonadal dysfunction undergoing haemodialysis. Clin Chim Acta 148: 239, 1985
Zetin M, Stone RA: Effects of zinc in chronic hemodialysis. Clin Nephrol 13: 20, 1980
Sprenger KBG, Bundschu D, Lewis K, Spohn B, Schmitz J, Franz H-E: Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: A double blind study. Kidney Int 24 (Supll 16): S315, 1983
Stoner HB, Barner JM, Duff JI: Studies on the toxicity of alkyl tin compounds. Br J Pharmacol 10: 16, 1955
Alajouanine T, Derobert L, Thieffry S: Etude clinique d’ensemble de 210 cas d’intoxication par les sels organiques d’etain. (Clinical study of 210 cases of intoxication by organic tin compounds.) Rev Neurol (Paris) 98: 85, 1973
Kappas A, Maines TD: Tin: A potent inducer of heme oxygenase in kidney. Science 192: 60, 1976
Stiefel EJ: Proposed molecular mechanism for the action of molybdenum in enzymes: coupled proton and electron transfers. Proc Natl Acad Sci USA 70: 988, 1973
Higgins ES, Reichert DA, Westerfeld WW: Molybdate deficiency and tungstate inhibition studies. J Nutr 59: 539, 1956
Bosshardt DK, Huff JS, Barner RH: Effect of bromine on chick growth. Proc Soc Exp Biol Med 92: 219, 1956
Huff JW, Bosshardt DK, Miller OP, Barner RH: A nutritional requirement for bromine. Proc Soc Exp Biol Med 92: 216, 1956
Carroll BJ, Sharp PT: Rubidium and lithium: opposite effects on amine-mediated excitement. Science 172: 1355, 1971
Fieve RR, Meitzer H, Dunner DL, Levitt M, Mendlewicz J, Thomas A: Rubidium: biochemical, behavioral and metabolic studies in humans. Am J Psychiat 130: 55, 1973
Hopkins LL Jr, Möhr HE: Vanadium as an essential nutrient. Fed Proc 33: 1773, 1974
Levine RA, Steeten DHP, Doisy RJ: Effects of oral chromium supplementation on the glucose tolerance test in the elderly. Metabolism 17: 114, 1968
O’Dell BL: Biochemistry and physiology of copper in vertebrates. in: Trace Elements in Human Health and Disease, edited by Prasad AS, New York, Academic Press, I, 1976, p 391
Russell JE, Avioli LV: Effect of progressive end-stage renal insufficiency on bone mineral-collagen maturation. Kidney Int 1 (Suppl 2): S97, 1975
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Alfrey, A.C. (1989). Trace Elements and Regular Dialysis. In: Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1087-4_49
Download citation
DOI: https://doi.org/10.1007/978-94-009-1087-4_49
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6979-3
Online ISBN: 978-94-009-1087-4
eBook Packages: Springer Book Archive